Next Century Growth Investors LLC Glaukos Corp Transaction History

Next Century Growth Investors LLC

  • $1.11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018
SELL
$24.5 - $36.01 $5.3 Million - $7.79 Million
-216,192 Closed
0 $0
Q3 2017

Nov 14, 2017
SELL
$31.26 - $42.03 $6.39 Million - $8.59 Million
-204,356 Reduced 48.59%
216,192 $7.13 Million
Q2 2017

Aug 14, 2017
BUY
N/A
420,548
420,548 $17.4 Million

Others Institutions Holding GKOS

# of Institutions
349
Shares Held
46.8M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Next Century Growth Investors LLC Portfolio

Follow Next Century Growth Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Century Growth Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email